Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

Overview of attention for article published in Advances in Therapy, July 2015

Altmetric Badge

Mentioned by

So far, Altmetric has seen 4 X posts from 2 X users, with an upper bound of 1,551 followers.

The FIRST LATAM study looking at the safety and tolerability of #fingolimod in #LatinAmerican patients with #MS http://t.co/RR89fDtfyk

Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The… http://t.co/tRcEQMECnk

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.